• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Radiologists overestimatemammo malpractice threat

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 4
Volume 31
Issue 4

The perceived threatof medical malpracticeclaims makes a biggerimpression on radiologiststhan is warrantedby the actual risk of litigation.

The perceived threat of medical malpractice claims makes a bigger impression on radiologists than is warranted by the actual risk of litigation.

Dr. John F. Dick III and colleagues at Dartmouth mailed surveys in 2006 to 118 radiologists who participated in any of three registries associated with the Breast Cancer Surveillance Consortium in Colorado, New Hampshire, and western Washington. They compared findings with those of a similar survey performed in 2002. Researchers found that the perceived risk of being sued is four times higher than the reported rate of malpractice claims.

In 2006, radiologists estimated that they had a 35% chance of facing a mammography- related malpractice suit in the next five years. In 2002, they rated the likelihood at 41%, but actual claim reports reached 8% in 2002 and 10% in 2006 (AJR 2009;192:327-333).

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.